Re-treatment with Tositumomab and Iodine I131 Tositumomab (the BEXXAR (R) therapeutic regimen) in patients with non-Hodgkin's lymphoma (NHL) with a previous response to the BEXXAR therapeutic regimen.

MS Kaminski; SJ Knox; J Radford; SA Gregory; JP Leonard

Re-treatment with Tositumomab and Iodine I131 Tositumomab (the BEXXAR (R) therapeutic regimen) in patients with non-Hodgkin's lymphoma (NHL) with a previous response to the BEXXAR therapeutic regimen.

MS Kaminski, SJ Knox, J Radford, SA Gregory, JP Leonard

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	407A
Number of pages	1
Journal	Blood
Volume	102
Issue number	11
Publication status	Published - 16 Nov 2003
Event	45th Annual Meeting of the American-Society-of-Hematology - San Diego, California, United States Duration: 6 Dec 2003 → 9 Dec 2003

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{6f8beeb09c93404b926b4ef38608f988,

title = "Re-treatment with Tositumomab and Iodine I131 Tositumomab (the BEXXAR (R) therapeutic regimen) in patients with non-Hodgkin's lymphoma (NHL) with a previous response to the BEXXAR therapeutic regimen.",

author = "MS Kaminski and SJ Knox and J Radford and SA Gregory and JP Leonard",

year = "2003",

month = nov,

day = "16",

language = "English",

volume = "102",

pages = "407A",

journal = "Blood",

issn = "0006-4971",

publisher = "Elsevier BV",

number = "11",

note = "45th Annual Meeting of the American-Society-of-Hematology ; Conference date: 06-12-2003 Through 09-12-2003",

}

Re-treatment with Tositumomab and Iodine I131 Tositumomab (the BEXXAR (R) therapeutic regimen) in patients with non-Hodgkin's lymphoma (NHL) with a previous response to the BEXXAR therapeutic regimen. / Kaminski, MS; Knox, SJ; Radford, J et al.
In: Blood, Vol. 102, No. 11, 16.11.2003, p. 407A.

Research output: Contribution to journal › Meeting Abstract › peer-review

TY - JOUR

T1 - Re-treatment with Tositumomab and Iodine I131 Tositumomab (the BEXXAR (R) therapeutic regimen) in patients with non-Hodgkin's lymphoma (NHL) with a previous response to the BEXXAR therapeutic regimen.

AU - Kaminski, MS

AU - Knox, SJ

AU - Radford, J

AU - Gregory, SA

AU - Leonard, JP

PY - 2003/11/16

Y1 - 2003/11/16

UR - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000186536701478&KeyUID=WOS:000186536701478

M3 - Meeting Abstract

SN - 0006-4971

VL - 102

SP - 407A

JO - Blood

JF - Blood

IS - 11

T2 - 45th Annual Meeting of the American-Society-of-Hematology

Y2 - 6 December 2003 through 9 December 2003

ER -

Re-treatment with Tositumomab and Iodine I131 Tositumomab (the BEXXAR (R) therapeutic regimen) in patients with non-Hodgkin's lymphoma (NHL) with a previous response to the BEXXAR therapeutic regimen.

UN SDGs

Other files and links

Cite this